-+ 0.00%
-+ 0.00%
-+ 0.00%

ROCHE RECEIVES FDA APPROVAL FOR COMPANION DIAGNOSTIC TESTS TO IDENTIFY PATIENTS WITH HER2-POSITIVE METASTATIC GASTROESOPHAGEAL ADENOCARCINOMA ELIGIBLE FOR ZIIHERA

路透·08/26/2026 18:52:37

登录查看新闻详情